nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Assessment of Lung Cancer Risks Related to Family History in Never-Smokers: A Cohort Study
|
Lee, Yun-Gyoo |
|
|
26 |
5 |
p. 364-369.e2 |
artikel |
2 |
Brief Report: The Effectiveness of Osimertinib in Advanced Nonsmall Cell Lung Cancer Harboring Various EGFR Exon 19 Mutation Variants
|
Chang, Lih-Chyun |
|
|
26 |
5 |
p. e353-e357.e2 |
artikel |
3 |
Brief Report: The Genomic Landscape of Small Cell Lung Cancer in Never-Smoking Patients
|
Oh, Michael S. |
|
|
26 |
5 |
p. 434-439.e3 |
artikel |
4 |
Clinical Sequence Revealed the Prevalence and Biological Significance of Somatic Pathogenic Variants in Thoracic Cancer: Implications for Germline Status
|
Fukushima, Takahiro |
|
|
26 |
5 |
p. 407-419.e20 |
artikel |
5 |
Comment on: Association of Sarcopenia with Toxicity and Survival in Patients With Lung Cancer, a Multi-Institutional Study With External Dataset Validation
|
Topkan, Erkan |
|
|
26 |
5 |
p. e325-e326 |
artikel |
6 |
Editorial Board
|
|
|
|
26 |
5 |
p. A1 |
artikel |
7 |
First Report of NSCLC With IDH1 Mutation: A Case Report
|
Zhang, Yuyue |
|
|
26 |
5 |
p. e321-e324 |
artikel |
8 |
Genetic Ancestry and Lung Cancer in Latin American Patients: A Crucial Step for Understanding a Diverse Population
|
Castañeda-González, Juan Pablo |
|
|
26 |
5 |
p. e342-e352 |
artikel |
9 |
Lung Carcinoid Tumors With Potentially Actionable Genomic Alterations and Responses to Targeted Therapies
|
Waliany, Sarah |
|
|
26 |
5 |
p. 354-363.e5 |
artikel |
10 |
Outcomes and Toxicity following 3 or More Definitive Courses of Thoracic Radiation Therapy for Non-Small Cell Lung Cancer
|
Odwuor, Abigael |
|
|
26 |
5 |
p. 384-392 |
artikel |
11 |
Predicting Severe Radiation Pneumonitis in Patients With Locally-Advanced Non–Small-Cell Lung Cancer After Thoracic Radiotherapy: Development and Validation of a Nomogram Based on the Clinical, Hematological, and Dose-Volume Histogram Parameters
|
Zhang, Ying |
|
|
26 |
5 |
p. 393-406 |
artikel |
12 |
Prognostic Implications of Lymph Node Status in Non–Small-Cell Lung Cancer Patients Before and After Neoadjuvant Chemoimmunotherapy: A Multicenter Retrospective Study
|
Ma, Ran |
|
|
26 |
5 |
p. 370-383 |
artikel |
13 |
Real-World Outcomes of Tarlatamab in Small Cell Lung Cancer, Including Patients With Untreated Brain Metastases
|
Bolte, Fabian J. |
|
|
26 |
5 |
p. 347-353.e1 |
artikel |
14 |
Systematic Review for the Follow-up of Curatively Treated Patients With Lung Cancer
|
Shargall, Yaron |
|
|
26 |
5 |
p. e327-e341 |
artikel |
15 |
Table of Contents
|
|
|
|
26 |
5 |
p. A3-A5 |
artikel |
16 |
The Role of GLP-1 Agonists in Mitigating Lorlatinib-Induced Metabolic Syndrome: Two Case Studies
|
Pietroluongo, Erica |
|
|
26 |
5 |
p. 429-433 |
artikel |
17 |
Young Onset Lung Cancer in India: Insights Into Clinical, Demographic, and Genomic Profiles
|
Malik, Prabhat Singh |
|
|
26 |
5 |
p. 420-428.e4 |
artikel |